Showing results (231-240 of 244) with videos related to
Sort By:
Pageof 25
Journal of the American College of Cardiology|April 2, 2013
Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health statusAmit P Amin, Alok Bachuwar, Kimberly J Reid, et al.European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.Journal of the American College of Cardiology|June 1, 1997
Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: a combined intravascular ultrasound Doppler flow and imaging studyM J Kern, P Dupouy, J H Drury, et al.Circulation. Cardiovascular Interventions|July 13, 2021
Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment ParadoxAmit P Amin, Sunil V Rao, Arnold H Seto, et al.European Heart Journal|April 1, 2014
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan K James, Richard G Bach, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2014
Conversations in cardiology: bridging antiplatelet therapy before surgeryMorton J Kern, Robert J Applegate, Malcolm Bell, et al.The American Journal of Cardiology|December 9, 2019
Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary InterventionAmit P Amin, John A Spertus, Hemant Kulkarni, et al.Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.Circulation. Heart Failure|August 1, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH TrialCatherine G Ireland, Danielle S Burstein, Sharlene M Day, et al.Pageof 25